123598-19-6

DT-5461 Chemical Structure
123598-19-6

Chemical Structure

DT-5461

  • CAS No.: 123598-19-6
  • Formula:C73H133N4O22P
  • Molecular Weight:1449.82

InChIKey: UJHMVJBHIMKLDF-BBAFUJFLSA-N

SMILES: CCCCCCCCCCCCCC(N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC[C@H]2O[C@@H]([C@@H]([C@H]([C@@H]2O)OC(CNC(CCCCCCCCCCC)=O)=O)NC(CCCCCCCCCCCCC)=O)OC(CC(O)=O)CC(O)=O)CO)OP(O)(O)=O)OC(CNC(CCCCCCCCCCC)=O)=O)=O

Biological Activity: DT-5461 is an IL-1 and TNF-α antagonist. DT-5461 competitively binds lipid A-binding sites on macrophage receptors, blocks LPS (HY-D1056)-initiated signaling, inhibits LPS-induced cytokine release, prevents LPS-induced serum cytokine production in mice, and protects against LPS-induced lethal endotoxemia. DT-5461 can be used for the research of lethal endotoxemia, medullary tubular mammary carcinoma, poorly differentiated colon adenocarcinoma, squamous-cell lung carcinoma, and gelatinous gastric adenocarcinoma[1][2][3].

Cat. No. Product Name Purity Description Pricing
HY-182377
DT-5461 DT-5461 is an IL-1 and TNF-α antagonist. DT-5461 competitively binds lipid A-binding sites on macrophage receptors, blocks LPS (HY-D1056)-initiated signaling, inhibits LPS-induced cytokine release, prevents LPS-induced serum cytokine production in mice, and protects against LPS-induced lethal endotoxemia. DT-5461 can be used for the research of lethal endotoxemia, medullary tubular mammary carcinoma, poorly differentiated colon adenocarcinoma, squamous-cell lung carcinoma, and gelatinous gastric adenocarcinoma.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

This compound is listed in the SVHC (Substances of Very High Concern) candidate list of ECHA (European Chemicals Agency).

Pricing 
Expand Hide

References